If your Medicare prescription drug insurance does not cover LOTEMAX® SM, LOTEMAX® Ointment, LOTEMAX® Gel (loteprednol etabonate ophthalmic gel) 0.5%, PROLENSA® or ZYLET®, or your out-of-pocket costs exceed $80* under that insurance, Bausch + Lomb may be able to help.
*Terms, conditions and limitations apply. Most eligible patients may pay as little as $80. See Eligibility Criteria/Terms and conditions below.
The Part D Program is valid for a cost reduction of a qualifying prescription of LOTEMAX® SM (loteprednol etabonate ophthalmic gel) 0.38%, LOTEMAX® Ointment (loteprednol etabonate ophthalmic ointment) 0.5%, LOTEMAX® Gel (loteprednol etabonate ophthalmic gel) 0.5%, PROLENSA® (bromfenac ophthalmic solution) 0.07%, or ZYLET® (loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension) for eligible patients.